Indications

July 4 trips expected to reach pre-pandemic levels

BUFFALO, NY (WKBW) – Independence Day weekend could be the first public holiday in more than a year to see pre-pandemic travel levels. “All indications now point to a busy Independence Day.” Paula Twidale, Senior Vice President, AAA Travel According to AAA, more than 47.7 million Americans are expected to …

Read More »

Cannabics Pharmaceuticals to Launch Drug Development Programs for Prostate Cancer and Neurodegenerative and Mental Health Diseases

TEL AVIV, Israel and BETHESDA, Maryland, June 17, 2021 / PRNewswire / – Cannabics Pharmaceuticals (OTCQB: CNBX), a global leader in the development of cancer-related cannabinoid drugs, today announced the expansion of its research program with new drug development projects targeting prostate cancer, neurodegenerative diseases and mental health. The announcement …

Read More »

Neo Medical obtains both FDA approval and CE mark

LAUSANNE, Switzerland, June 16, 2021 / PRNewswire / – Neo Medical, a Switzerland-based medical technology company developing value-based care solutions for functional fusion in spine surgery, today announced two major regulatory milestones for European markets and American. First, Neo Medical received 510 (k) clearance from the FDA for the use …

Read More »

AVITA Medical announces preliminary fourth quarter 2021

VALENCIA, California and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) – AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that develops and markets a technology platform that enables the restoration of autologous skin care for multiple unmet needs, today announced unaudited preliminary financial results for fiscal fourth …

Read More »

US FDA approved IND application to study combination of APL-1202 from Asieris and Tislelizumab from BeiGene as a neoadjuvant therapy for patients with MIBC

SHANGHAI, June 14, 2021 / PRNewswire / – Asieris Pharmaceuticals (Asieris) today announced that the United States Food and Drug Administration (FDA) has approved the application of a new investigational drug (IND) of APL-1202 via the orally in combination with BeiGene’s tislelizumab as a neoadjuvant therapy in patients with bladder …

Read More »